Sense of Hope Alleviates Fatigue in Breast Cancer Survivors
22 mars 2015 mis à jour par: National Taiwan University Hospital
The Sense of Hope Alleviates Fatigue in Breast Cancer Survivors
This study explores the relationship between the sense of hope and fatigue in breast cancer survivors and provides a reference for future planning improvements for breast cancer survivors experiencing fatigue.
Aperçu de l'étude
Statut
Inconnue
Les conditions
Description détaillée
Breast cancer is an important and escalating issue for females all over the world. Due to the improvement of medical and technological progress, the survival rate of breast cancer patient increases every year. Breast cancer survivors, after the discomforting distress from cancer treatment, will go through treatment-derived physical distress and worry about relapse. As a result the fatigue in breast cancer survivors has not been reduced after primary treatment. Feeling fatigue in a long term will bring mental illness problems ,decrease the quality of life and weaken the will to survive. A sense of hope in the face of fatigue may serve as an important driving force and enhance the survivors' will to survive. This study explores the relationship between the sense of hope and fatigue in breast cancer survivors and provides a reference for future planning improvements for breast cancer survivors experiencing fatigue.
A cross-sectional study design is adopted for this study. The study expects to collect 200 questionnaires from breast cancer survivors through medical centers treating breast cancer and breast cancer patients communities. The questionnaire includes (a) the basic demographic information (b) disease history (c) social support scale; (d) short version multiaxial fatigue syndrome scale; (e) Hearst hope scale.
Answered questionnaires will be input to spreadsheets for further statistical analysis using SPSS 19.0 statistical software packages.
Type d'étude
Observationnel
Inscription (Anticipé)
180
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Taipei, Taïwan, 10002
- Recrutement
- National Taiwan University Hospital
-
Contact:
- Chuang Pei-Hsuan
- Numéro de téléphone: 886-918559583
- E-mail: amy67274@hotmail.com
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
20 ans à 90 ans (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Femelle
Méthode d'échantillonnage
Échantillon non probabiliste
Population étudiée
breast cancer survivors,complete chemotherapy and radiotherapy
La description
Inclusion criteria:
- diagnosed as a breast cancer patient
- complete operation,chemotherapy and radiation therapy
- understand the treatment and condition by herself
- conscious clear who can speaking Mandarin or: Taiwanese
- after consenting , the participant agree to participate orally or write down in the consent form
Exclusion criteria:
- Can not speaking Mandarin or Taiwanese
- Psychotic or Understanding barriers
- refuse verbally or write the Consent Form
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Perspectives temporelles: Transversale
Cohortes et interventions
Groupe / Cohorte |
|---|
|
Breast cancer survivor
Females finished primary breast cancer treatment including surgical operation, radiation therapy and chemotherapy.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Multidimensional Fatigue Symptom Inventory-Short Form
Délai: Baseline measured after the completion of breast cancer surgery, radiation therapy and chemotherapy
|
A 30-item self-report questionnaire designed to assess the severity, frequency, and daily pattern of fatigue as well as its perceived interference with quality of life.
|
Baseline measured after the completion of breast cancer surgery, radiation therapy and chemotherapy
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Herth Hope Index
Délai: Baseline measured after the completion of breast cancer surgery, radiation therapy and chemotherapy
|
A 12-item self-report questionnaire containing three dimensions: temporality and future, positive readiness and expectancy, and interconnectedness.
Tested on family caregivers of terminally ill people and terminally ill persons as well as in community and hospital patients and family members.
(Herth, 1990)
|
Baseline measured after the completion of breast cancer surgery, radiation therapy and chemotherapy
|
|
The Inventory of Socially Supportive Behaviors
Délai: Baseline measured after the completion of breast cancer surgery, radiation therapy and chemotherapy
|
A 40-item self-report questionnaire designed to assess how often individuals received various forms of assistance during the preceding month, such as directive guidance (e.g., offering advice), nondirective support (e.g., listening and reflecting), positive social exchange (e.g., expressing confidence and encouragement), and tangible assistance (e.g., providing materials or services).
(Barrera, Sandler, & Ramsay, 1981).
|
Baseline measured after the completion of breast cancer surgery, radiation therapy and chemotherapy
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Chercheur principal: ChunaNG Pei-Hsuan, National Taiwan University Hospital
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Publications générales
- Berger AM, Gerber LH, Mayer DK. Cancer-related fatigue: implications for breast cancer survivors. Cancer. 2012 Apr 15;118(8 Suppl):2261-9. doi: 10.1002/cncr.27475.
- Alexander S, Minton O, Andrews P, Stone P. A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer. 2009 Feb;45(3):384-92. doi: 10.1016/j.ejca.2008.09.010. Epub 2008 Oct 30.
- Brady MJ, Peterman AH, Fitchett G, Mo M, Cella D. A case for including spirituality in quality of life measurement in oncology. Psychooncology. 1999 Sep-Oct;8(5):417-28. doi: 10.1002/(sici)1099-1611(199909/10)8:53.0.co;2-4.
- Dizon DS. Quality of life after breast cancer: survivorship and sexuality. Breast J. 2009 Sep-Oct;15(5):500-4. doi: 10.1111/j.1524-4741.2009.00766.x. Epub 2009 Jul 14.
- Gielissen MF, Wiborg JF, Verhagen CA, Knoop H, Bleijenberg G. Examining the role of physical activity in reducing postcancer fatigue. Support Care Cancer. 2012 Jul;20(7):1441-7. doi: 10.1007/s00520-011-1227-4. Epub 2011 Jul 21.
- Goldstein D, Bennett BK, Webber K, Boyle F, de Souza PL, Wilcken NR, Scott EM, Toppler R, Murie P, O'Malley L, McCourt J, Friedlander M, Hickie IB, Lloyd AR. Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study. J Clin Oncol. 2012 May 20;30(15):1805-12. doi: 10.1200/JCO.2011.34.6148. Epub 2012 Apr 16.
- Hoffman AJ, von Eye A, Gift AG, Given BA, Given CW, Rothert M. Testing a theoretical model of perceived self-efficacy for cancer-related fatigue self-management and optimal physical functional status. Nurs Res. 2009 Jan-Feb;58(1):32-41. doi: 10.1097/NNR.0b013e3181903d7b.
- Howard-Anderson J, Ganz PA, Bower JE, Stanton AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst. 2012 Mar 7;104(5):386-405. doi: 10.1093/jnci/djr541. Epub 2012 Jan 23.
- Koch L, Jansen L, Herrmann A, Stegmaier C, Holleczek B, Singer S, Brenner H, Arndt V. Quality of life in long-term breast cancer survivors - a 10-year longitudinal population-based study. Acta Oncol. 2013 Aug;52(6):1119-28. doi: 10.3109/0284186X.2013.774461. Epub 2013 Mar 20.
- Mattioli JL, Repinski R, Chappy SL. The meaning of hope and social support in patients receiving chemotherapy. Oncol Nurs Forum. 2008 Sep;35(5):822-9. doi: 10.1188/08.ONF.822-829.
- Olson K. A new way of thinking about fatigue: a reconceptualization. Oncol Nurs Forum. 2007 Jan;34(1):93-9. doi: 10.1188/07.ONF.93-99.
- Piper BF, Cella D. Cancer-related fatigue: definitions and clinical subtypes. J Natl Compr Canc Netw. 2010 Aug;8(8):958-66. doi: 10.6004/jnccn.2010.0070.
- Ribi K, Bernhard J, Rufibach K, Thurlimann B, von Moos R, Ruhstaller T, Glaus A, Bohme C. Endocrine symptom assessment in women with breast cancer: what a simple "yes" means. Support Care Cancer. 2007 Dec;15(12):1349-56. doi: 10.1007/s00520-007-0258-3. Epub 2007 May 26.
- Rustoen T, Cooper BA, Miaskowski C. The importance of hope as a mediator of psychological distress and life satisfaction in a community sample of cancer patients. Cancer Nurs. 2010 Jul-Aug;33(4):258-67. doi: 10.1097/NCC.0b013e3181d6fb61.
- Trudel-Fitzgerald C, Savard J, Ivers H. Evolution of cancer-related symptoms over an 18-month period. J Pain Symptom Manage. 2013 Jun;45(6):1007-18. doi: 10.1016/j.jpainsymman.2012.06.009. Epub 2012 Sep 24.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 janvier 2015
Achèvement primaire (Anticipé)
1 juillet 2015
Achèvement de l'étude (Anticipé)
1 juillet 2015
Dates d'inscription aux études
Première soumission
6 janvier 2015
Première soumission répondant aux critères de contrôle qualité
18 mars 2015
Première publication (Estimation)
19 mars 2015
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
24 mars 2015
Dernière mise à jour soumise répondant aux critères de contrôle qualité
22 mars 2015
Dernière vérification
1 mars 2015
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 201411051RINB
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .